ACRV Schedule 13D/A Filing Summary

This filing is an amendment to a previous Schedule 13D, reporting a dilution in beneficial ownership of ACRIVON THERAPEUTICS, INC. common stock by RA Capital Management, L.P. and related entities. The reporting persons, including RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P., collectively hold 8,396,018 shares, representing 21.6% ownership. This amendment is not due to any acquisition or disposition of securities but rather a result of dilution. No transactions were effected in the 60 days prior to filing. The filing details the structure of the reporting persons and their beneficial ownership, with RA Capital Management acting as the investment adviser and holding voting and dispositive power for the shares held by the funds.